HLA-DRB1 and cancer: Genes in response to interferon gamma, including CCL20, CCL25 and CD74, and antigen presentation-related genes, such as HLA-DPA1, HLA-DRA and HLA-DRB, were significantly upregulated in the cancer cells of immune-rich type tumors (Fig. 3F).